Enhanced drug loading on magnetic nanoparticles by layer-by-layer assembly using drug conjugates: blood compatibility evaluation and targeted drug delivery in cancer cells.

Drug targeting using magnetic nanoparticles (MNPs) under the action of an external magnetic field constitutes an important mode of drug delivery. Low cargo capacity, particularly in hydrophobic drugs, is one limitation shown by MNPs. This article describes a simple strategy to enhance the drug-loading capacity of MNPs. The approach was to use polymer-drug conjugates to modify MNPs by layer-by-layer assembly (LbL). Curcumin (CUR) has shown remarkably high cytotoxicity toward various cancer cell lines. However, the drug shows low anticancer activity in vivo because of its reduced systemic bioavailability acquired from its poor aqueous solubility and instability. To address this issue, we synthesized cationic and anionic CUR conjugates by anchoring CUR onto poly(vinylpyrroidone) (PVP-Cur) and onto hyaluronic acid (HA-Cur). We used these oppositely charged conjugates to modify MNPs by layer-by-layer (LbL) assembly. Six double layers of curcumin conjugates were constructed on positively charged amino-terminated magnetic nanoparticles, TMSPEDA@MNPs. Finally, HA was coated onto the outer surface to form HA (HA-Cur/PVP-Cur)(6)@MNPs. Cellular viability studies showed the dose-dependent antiproliferative effect of HA (HA-Cur/PVP-Cur)(6)@MNPs in two cancer cell lines (glioma cells and Caco-2 cells). HA (HA-Cur/PVP-Cur)(6)@MNPs exhibited more cytotoxicity than did free curcumin, which was attributed to the enhanced solubility along with better absorption via hyaluronic acid receptor-mediated endocytosis. Flow cytometry showed enhanced intake of the modified MNPs by cells. Confocal microscope images also confirmed the uptake of HA (HA-Cur/PVP-Cur)(6)@MNPs with greater efficacy. Thus, the strategy that we adopted here appears to have substantial potential in carrying enhanced payloads of hydrophobic drugs to specified targets.

[1]  H. Toma,et al.  Preparation and characterization of (3-aminopropyl) triethoxysilane-coated magnetite nanoparticles , 2004 .

[2]  A Garg,et al.  Nuclear transcription factor-κB as a target for cancer drug development , 2002, Leukemia.

[3]  Wei Guo,et al.  Fabrication of Magnetic Luminescent Nanocomposites by a Layer-by-Layer Self-assembly Approach , 2004 .

[4]  Tiago R. Oliveira,et al.  Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment , 2011, International journal of nanomedicine.

[5]  Tak W. Kee,et al.  Effective stabilization of curcumin by association to plasma proteins: human serum albumin and fibrinogen. , 2009, Langmuir : the ACS journal of surfaces and colloids.

[6]  G. Sukhorukov,et al.  Magnetic targeting and cellular uptake of polymer microcapsules simultaneously functionalized with magnetic and luminescent nanocrystals. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[7]  K. Powers,et al.  Physicochemical properties and blood compatibility of acylated chitosan nanoparticles , 2004 .

[8]  Yu-Kyoung Oh,et al.  Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[9]  Joshua S. Katz,et al.  Indian gold treating cancer in the age of nano , 2011, Cancer biology & therapy.

[10]  S. Laurent,et al.  Superparamagnetic nanosystems based on iron oxide nanoparticles for biomedical imaging. , 2011, Nanomedicine.

[11]  R. Kurzrock,et al.  Liposomal curcumin with and without oxaliplatin: effects on cell growth, apoptosis, and angiogenesis in colorectal cancer , 2007, Molecular Cancer Therapeutics.

[12]  Zhiyong Tang,et al.  Biomedical Applications of Layer‐by‐Layer Assembly: From Biomimetics to Tissue Engineering , 2006 .

[13]  U. Bandyopadhyay,et al.  Turmeric and curcumin: Biological actions and medicinal applications , 2004 .

[14]  S. Manju,et al.  Synthesis and characterization of a cytotoxic cationic polyvinylpyrrolidone-curcumin conjugate. , 2011, Journal of pharmaceutical sciences.

[15]  Jianmin Xing,et al.  Preparation and characterization of amino-silane modified superparamagnetic silica nanospheres , 2004 .

[16]  B. Li,et al.  Functionalized magnetic-fluorescent hybrid nanoparticles for cell labelling. , 2011, Nanoscale.

[17]  Keliang Liu,et al.  Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery. , 2011, Biomaterials.

[18]  David Bardenstein,et al.  Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery. , 2009, Molecular pharmaceutics.

[19]  W. You,et al.  Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin , 1999, Breast Cancer Research and Treatment.

[20]  B. Aggarwal,et al.  Nuclear factor-kappaB: the enemy within. , 2004, Cancer cell.

[21]  J. Fraser,et al.  Hyaluronan: its nature, distribution, functions and turnover , 1997, Journal of internal medicine.

[22]  Gero Decher,et al.  Fuzzy Nanoassemblies: Toward Layered Polymeric Multicomposites , 1997 .

[23]  K. Chennazhi,et al.  Curcumin-loaded biocompatible thermoresponsive polymeric nanoparticles for cancer drug delivery. , 2011, Journal of colloid and interface science.

[24]  B. Aggarwal,et al.  Anticancer potential of curcumin: preclinical and clinical studies. , 2003, Anticancer research.

[25]  O. Zelphati,et al.  Nucleic acid delivery using magnetic nanoparticles: the Magnetofection technology. , 2011, Therapeutic delivery.

[26]  D. Jaillard,et al.  Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments. , 2005, Bioconjugate chemistry.

[27]  B. Zhang,et al.  Curcumin polymers as anticancer conjugates. , 2010, Biomaterials.

[28]  T. Laurent.  Biochemistry of hyaluronan. , 1987, Acta oto-laryngologica. Supplementum.

[29]  Jean Paul Remon,et al.  Polymeric multilayer capsules in drug delivery. , 2010, Angewandte Chemie.

[30]  O. P. Sharma.  Antioxidant activity of curcumin and related compounds. , 1976, Biochemical pharmacology.

[31]  Ricky A. Sharma,et al.  Curcumin: the story so far. , 2005, European journal of cancer.

[32]  E. Syková,et al.  Poly(N,N-dimethylacrylamide)-coated maghemite nanoparticles for stem cell labeling. , 2009, Bioconjugate chemistry.

[33]  A. Gaharwar,et al.  Magnetic nanoparticle-polyelectrolyte interaction: a layered approach for biomedical applications. , 2008, Journal of Nanoscience and Nanotechnology.

[34]  Yuetsu Tanaka,et al.  Retracted: Curcumin (diferuloylmethane) inhibits constitutive active NF‐κB, leading to suppression of cell growth of human T‐cell leukemia virus type I‐infected T‐cell lines and primary adult T‐cell leukemia cells , 2006 .

[35]  S. Manju,et al.  Conjugation of curcumin onto hyaluronic acid enhances its aqueous solubility and stability. , 2011, Journal of colloid and interface science.

[36]  Shao-pu Liu,et al.  A study on the sizes and concentrations of gold nanoparticles by spectra of absorption, resonance Rayleigh scattering and resonance non-linear scattering. , 2005, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[37]  R. Savani,et al.  Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation , 1995, Cell.

[38]  Yang Zhou,et al.  Layer-by-Layer self-assembly of polyaspartate and Poly(ethyleneimine) on magnetic nanoparticles: Characterization and adsorption of protein , 2011 .

[39]  C. O'connor,et al.  Synthesis of Variable-Sized Nanocrystals of Fe3O4 with High Surface Reactivity , 2004 .

[40]  Johannes Schmitt,et al.  Buildup of ultrathin multilayer films by a self-assembly process: III. Consecutively alternating adsorption of anionic and cationic polyelectrolytes on charged surfaces , 1992 .